Neonatal Toxicology Market Size Worth USD 22.22 Billion by 2034 | CAGR: 7.65%

The neonatal toxicology market size is expected to reach USD 22.22 Billion by 2034, according to a new study by Polaris Market Research. The report “Neonatal Toxicology Market Size, Share, Trends, Industry Analysis Report By Specimen (Urine, Umbilical Cord, Meconium, And Others), By Technology, By Drug, By End Use, and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The neonatal toxicology market provides solutions for early detection, monitoring, and management of drug exposure and toxic substances in newborns, covering hospitals, diagnostic laboratories, and research institutions. Market growth is driven by increasing awareness of neonatal health, rising incidence of neonatal disorders, and the need for early intervention.

Request a free sample copy or read the full market insights :  neonatal toxicology market report

In addition, growing investments in advanced diagnostic services and technologies and adoption of non-invasive testing methods are accelerating the use of accurate, rapid, and reliable neonatal toxicology solutions globally.

Neonatal Toxicology Market Report Highlights

• Based on Specimen, the meconium segment dominated in 2024, owing to its ability to provide a longer detection window for prenatal drug exposure.
• In terms of Technology, the immunoassay segment held the largest share, due to its wide clinical adoption, faster processing, and cost-effectiveness for routine neonatal screening.
• Based on Drug, the opioids segment led the market, driven by rising incidence of neonatal opioid withdrawal syndrome (NOWS) in several countries.
• In terms of End Use, hospitals dominated, as they serve as the primary centers for immediate neonatal screening and early intervention.
• North America led the market in 2024, fueled by high prevalence of neonatal exposure to drugs, including opioids and prescription medications.
• Asia Pacific is expected to witness strong growth, supported by increasing awareness among healthcare professionals and parents regarding neonatal health and early intervention.
• Key players in the global market include Agilent Technologies, Inc., ARUP Laboratories, Inc., Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Clinical Reference Laboratory, Inc., Cordant Health Solutions, Inc., Eurofins Scientific SE, Labcorp Holdings, Inc., Medpace Holdings, Inc., Omega Laboratories, Inc., QuidelOrtho Corporation, Quest Diagnostics Incorporated, Thermo Fisher Scientific, Inc., United States Drug Testing Laboratories, Inc. (USDTL), and WuXi AppTec Co., Ltd.

Polaris Market Research has segmented the market report based on specimen, technology, drug, end use, and region:

By Specimen Outlook (Revenue, USD Billion, 2020–2034)

• Urine
• Umbilical Cord
• Meconium
• Others

By Technology Outlook (Revenue, USD Billion, 2020–2034)

• Mass spectroscopy
• Immunoassay

By Drug Outlook (Revenue, USD Billion, 2020–2034)

• Cannabinoids
• Opioids
• Cocaine
• Benzodiazepines
• Amphetamines
• Other illicit drugs

By End Use Outlook (Revenue, USD Billion, 2020–2034)

• Hospitals
• Clinical Laboratories
• Others

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America

• US
• Canada

• Europe

• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe

• Asia Pacific

• China
• Japan
• India
• Malaysia
• South Korea
• Indonesia
• Australia
• Vietnam
• Rest of Asia Pacific

• Middle East & Africa

• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa

• Latin America

• Mexico
• Brazil
• Argentina
• Rest of Latin America